NEWS

Stay up-to-date with news about NeuroPro’s clinical development progress

Key milestones

from 10:00 AM
to 10:30 AM PDT

2019: NeuroPro secures $10 million for preclinical development and a Phase 1 study.

from 10:00 AM
to 10:30 AM PDT

August 2022: NeuroPro files an IND with the FDA to initiate a Phase 1 study.

from 10:00 AM
to 10:30 AM PDT

October 2022: NeuroPro initiates Phase 1.

from 10:00 AM
to 10:30 AM PDT

February 2023: NeuroPro secures $5 million in equity funding to prepare for Phase 2.

from 10:00 AM
to 10:30 AM PDT

March 2023: NeuroPro completes NPT 2042 Phase 1 study.